SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-268895
Filing Date
2011-10-12
Accepted
2011-10-12 07:27:53
Documents
3
Period of Report
2011-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d242466d8k.htm 8-K 15450
2 PRESS RELEASE d242466dex991.htm EX-99.1 7470
3 GRAPHIC g242466ex991_img001.jpg GRAPHIC 8677
  Complete submission text file 0001193125-11-268895.txt   36386
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 111136564
SIC: 2834 Pharmaceutical Preparations